Celltrion to Start Coronavirus Vaccine Trial

  • Arirang News

    August 27, 2020 08:42

    The Ministry of Food and Drug Safety on Tuesday approved a phase one clinical trial of a coronavirus vaccine being developed by pharmaceutical company Celltrion.

    According to the company, researchers can now administer CT-P59 to nine patients with mild coronavirus symptoms in Korea and another nine in U.K.

    CT-P59 is a genetically modified antibody treatment that the company is developing. It is the first to receive clinical approval in Korea.

    • Copyright © Chosunilbo & Chosun.com
    Previous Next
    All Headlines Back to Top